Bengaluru-based health tech firm Tricog has raised $8.5 million in a Series B2 funding round from Omron Healthcare and Sony Innovation Fund, in Japan. Existing investors UTEC - The University of Tokyo Edge Capital, Japan, Inventus Partners LLP and SG Innovate, Singapore, participated in this round.
The round marks a total raise of $30 million. Tricog’s artificial intelligence (AI) platform, backed by medical experts, has touched the lives of more than 12 million patients globally, enabling half a million patients added to the care pathway due to critical diseases. Tricog aims to make cardiac diagnosis and management accessible and affordable by deepening the partnerships with government and large private healthcare networks and building state-of-the-art technology for next-generation products, enabling wider reach in patient populations and disease conditions.
Founded in 2015, Tricog has recently developed the TriCare platform, an integrated solution for chronic disease management. The first focus will address the global healthcare challenge of heart failure within the US healthcare system and Asia. The TriCare platform enables remote management of heart disease using medical data from connected devices at home and wearable devices such as the Apple Watch. The TriCare platform addresses a growing $110 billion market segment opportunity.
